These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2814944)

  • 1. Effects of Hydergine on platelet deposition on "active" human carotid artery lesions and platelet function.
    Steurer G; Fitscha P; Ettl K; Sinzinger H
    Thromb Res; 1989 Sep; 55(5):577-89. PubMed ID: 2814944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double blind study of the influence of co-dergocrine on platelet parameters in healthy volunteers.
    Sinzinger H
    Eur J Clin Pharmacol; 1985; 28(6):713-6. PubMed ID: 2998802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravenous high dose co-dergocrine mesylate ('Hydergine') in elderly patients with severe multi-infarct dementia: a double-blind, placebo-controlled trial.
    Arrigo A; Casale R; Giorgi I; Guarnaschelli C; Zelaschi F
    Curr Med Res Opin; 1989; 11(8):491-500. PubMed ID: 2680286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of co-dergocrine on platelet aggregation.
    Santos RO; Rodrigues R
    Braz J Med Biol Res; 1990; 23(3-4):325-7. PubMed ID: 2094545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-term study with co-dergocrine mesylate (Hydergine) in healthy pensioners. Results after 3 years.
    Köberle S; Spiegel R
    Gerontology; 1984; 30 Suppl 1():3-52. PubMed ID: 6489764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-dergocrine (hydergine) in the treatment of tardive dyskinesia.
    Rastogi SC; Blowers AJ; Gibson AC
    Psychol Med; 1982 May; 12(2):427-9. PubMed ID: 6124989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium.
    von Hundelshausen P; Weber KS; Huo Y; Proudfoot AE; Nelson PJ; Ley K; Weber C
    Circulation; 2001 Apr; 103(13):1772-7. PubMed ID: 11282909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly constrained cyclic (S,S)-CDC- peptide is a potent inhibitor of carotid artery thrombosis in rabbits.
    Roussa VD; Stathopoulou EM; Papamichael ND; Englezopoulos CV; Rousouli KI; Trypou P; Moussis V; Tellis CC; Katsouras CS; Tsikaris V; Tselepis AD; Michalis LK
    Platelets; 2011; 22(5):361-70. PubMed ID: 21158497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of asthmatic patients using an alpha-adrenergic receptor blocking agent, co-dergocrine mesylate ('Hydergine').
    Kitamura S
    Pharmatherapeutica; 1980; 2(5):330-6. PubMed ID: 7433473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of co-dergocrine mesylate (Hydergine) in multi-infarct dementia as evaluated by positron emission tomography.
    Nagasawa H; Kogure K; Kawashima K; Ido T; Itoh M; Hatazawa J
    Tohoku J Exp Med; 1990 Nov; 162(3):225-33. PubMed ID: 2091324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of isradipine on in-vivo platelet function.
    O'Grady J; Kritz H; Schmid P; Pirich C; Sinzinger H
    Thromb Res; 1997 Jun; 86(5):363-71. PubMed ID: 9211627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of TRK-100, a stable orally active prostacyclin analogue, on platelet function and plaque size in atherothrombotic strokes.
    Isaka Y; Handa N; Imaizumi M; Kimura K; Kamada T
    Thromb Haemost; 1991 Apr; 65(4):344-50. PubMed ID: 2057914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion, decreases platelet aggregation and intimal hyperplasia in a rat carotid endarterectomy model.
    Cruz CP; Eidt J; Drouilhet J; Brown AT; Wang Y; Barnes CS; Moursi MM
    J Vasc Surg; 2001 Oct; 34(4):724-9. PubMed ID: 11668330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques.
    van Montfoort ML; Kuijpers MJ; Knaup VL; Bhanot S; Monia BP; Roelofs JJ; Heemskerk JW; Meijers JC
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1668-73. PubMed ID: 24947525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local delivery of platelets with encapsulated iloprost to balloon injured pig carotid arteries: effect on platelet deposition and neointima formation.
    Banning A; Brewer L; Wendt M; Groves PH; Cheadle H; Penny WJ; Crawford N
    Thromb Haemost; 1997 Jan; 77(1):190-6. PubMed ID: 9031472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The double-tuck model: a new animal model of arterial thrombosis.
    Gomez-Jorge J; Becker GJ; Rodriguez MM; Halgowich J; Leone J
    J Vasc Interv Radiol; 1998; 9(4):633-8. PubMed ID: 9684835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model.
    Huang J; Driscoll EM; Gonzales ML; Park AM; Lucchesi BR
    J Pharmacol Exp Ther; 2000 Nov; 295(2):492-9. PubMed ID: 11046080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation.
    Massberg S; Brand K; Grüner S; Page S; Müller E; Müller I; Bergmeier W; Richter T; Lorenz M; Konrad I; Nieswandt B; Gawaz M
    J Exp Med; 2002 Oct; 196(7):887-96. PubMed ID: 12370251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the in vivo efficacy of GPIIb/IIIa receptor antagonists (m7E3, MK-383 and DMP-728) and ex vivo platelet inhibition.
    Huang J; Rebello SS; Faul JD; Lucchesi BR
    Pharmacology; 1999 May; 58(5):252-64. PubMed ID: 10087466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II).
    Byington RP; Furberg CD; Crouse JR; Espeland MA; Bond MG
    Am J Cardiol; 1995 Sep; 76(9):54C-59C. PubMed ID: 7572688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.